title: Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen: implications for lymphomagenesis in acquired immunodeficiency syndrome.
abstract: In a previous study, we described a cell line (BRG-P) derived from a woman with Burkitt's lymphoma (BL) and acquired immunodeficiency syndrome that shared the same characteristic cytogenetic abnormalities as the patient's malignant cells. This cell line contained subclones that displayed an isotype switch from IgM to IgA1 and an accumulation of point mutations in the Vh region genes. Because these two features suggested an antigen-driven process, we began a search for the antigen responsible for the stimulation of the malignant B cells. Specifically, we hypothesized that because the patient's tumor had presented as a lymphomatous infiltration of the breast, the malignant B cells were recruited to this site because of the reactivity of their surface lg with breast tissue. A hybridoma (BRG-H) was obtained by fusing BRG-M cells (an IgM producing subclone of the BRG-P cell) with an appropriate cellular partner. The monoclonal antibody (BRG MoAb) produced by this hybridoma reacted strongly with two of five breast cancer cell lines and stained normal and malignant ductal epithelial cells on breast tissue sections. The antigen recognized by the BRG MoAb consisted of a single, minimally glycosylated polypeptide chain of 45 kD (p45). The BRG MoAb failed to react with a panel of human cell lines from different tissues, except for one cell line from a uterine cervical carcinoma. No reactivity was detected for a panel of exogenous antigens from various pathogens, including human immunodeficiency virus and self-antigens frequently recognized by polyspecific antibodies. Experiments were performed to investigate the functional consequences of the interaction of surface IgM with its specific ligand. Coculture of BRG-M cells with p45+, but not with p45-, breast cells caused apoptosis of BRG-M cells. The specificity of the interaction was shown by the observation that apoptosis was prevented by pretreatment of BRG-M cells with a monovalent F(ab') fragment of rabbit IgG antibody to human mu chains. Moreover, only BRG-M cells, but not other BL cells, underwent apoptosis after exposure to p45+ breast cells. The interaction between the CD40 molecule expressed by BRG-M cells and its specific ligand (CD40L) prevented p45-induced cell apoptosis. Because this interaction mimics that occurring in vivo between T and B cells during immune responses, our data suggest that various events contributed to the emergence of the BL, in this particular patient, including antigenic stimulation possibly assisted by T-cell help.
authors.affiliation: Servizi di Immunologia Clinica e Patologia Clinica, Istituto Nazionale per la Ricerca sul Cancro-IST, Genova, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Roncella
authors.forename: G
authors.initials: G
authors.lastname: Cutrona
authors.forename: A
authors.initials: A
authors.lastname: Favre
authors.forename: M
authors.initials: M
authors.lastname: Ulivi
authors.forename: F
authors.initials: F
authors.lastname: Fais
authors.forename: A
authors.initials: A
authors.lastname: Signorini
authors.forename: C E
authors.initials: CE
authors.lastname: Grossi
authors.forename: N
authors.initials: N
authors.lastname: Chiorazzi
authors.forename: M
authors.initials: M
authors.lastname: Ferrarini
mesh_terms: D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm / Q000276:immunology*; D017209:Apoptosis / Q000502:physiology*; D001324:Autoantigens / Q000276:immunology*; D001940:Breast / Q000276:immunology; D001943:Breast Neoplasms / Q000276:immunology / Q000473:pathology*; D002051:Burkitt Lymphoma / Q000276:immunology / Q000473:pathology*; D023201:CD40 Ligand; D018270:Carcinoma, Ductal, Breast / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000276:immunology*; D018920:Coculture Techniques; D004848:Epithelium / Q000276:immunology; D005260:Female; D006801:Humans; D006825:Hybridomas / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology*; D007519:Isoantigens / Q000276:immunology*; D008175:Lung Neoplasms / Q000276:immunology / Q000473:pathology; D016483:Lymphoma, AIDS-Related / Q000209:etiology / Q000276:immunology / Q000473:pathology*; D008562:Membrane Glycoproteins / Q000502:physiology; D008954:Models, Biological; D009363:Neoplasm Proteins / Q000276:immunology*; D011817:Rabbits; D011947:Receptors, Antigen, B-Cell / Q000276:immunology*; D014407:Tumor Cells, Cultured
chemical_list: D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D001324:Autoantigens; D007075:Immunoglobulin M; D007519:Isoantigens; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D011947:Receptors, Antigen, B-Cell; D023201:CD40 Ligand